USAMRIID IACUC specifically approved this study. The Culex tarsalis colony used for all experiments was derived from field mosquitoes 1 1 8 collected in Yolo County, CA in 2009. Mosquitoes were reared and maintained at 27°C ± 1°C, 1 1 9 12:12 hr light:dark diurnal cycle at 80% relative humidity in 30×30×30 cm cages. The wAlbB 1 2 0
Wolbachia strain was purified from An. gambiae Sua5B cells, according to published protocols 1 2 1 [36] . Wolbachia viability and density was assessed using the LIVE/DEAD BacLight Bacterial 1 2 2 Viability Kit (Invitrogen, Carlsbad, CA) and a hemocytometer. The experiment was replicated 1 2 3 three times and wAlbB concentrations were as follows: replicate one, 2.5 × 10 9 bacteria/ml; 1 2 4 replicate two, 2.5 × 10 9 bacteria/ml; replicate three, 5.0 × 10 9 bacteria/ml. Two-to 4-day-old adult female Cx. tarsalis were anesthetized with CO 2 and 1 2 6
intrathoracically injected with approximately 0.1 µl of either suspended wAlbB or Schneider's 1 2 7 7 insect media (Sigma Aldrich, Saint Louis, MO) as a control. Mosquitoes were provided with 1 2 8 10% sucrose ad libitum and maintained at 27°C in a growth chamber. blinded. Mosquitoes were allowed to feed for one hour. After this period, hamsters were 1 4 0 removed, a blood sample taken to determine viremia, and hamsters were euthanized. After feeding, mosquitoes were anesthetized with CO 2 and examined for feeding status; 1 4 2 partially or non-blood fed females were discarded. For all replicates, one blood fed mosquito 1 4 3 from each treatment was sampled to test for input viral titers. Mosquitoes were sampled at 7 and 1 4 4 14 days post-blood feeding, where they were anesthetized with CO 2, and had their legs removed. Dulbecco's phosphate-buffered saline, 50 µg/ml penicillin streptomycin, and 2.5 µg/ml 1 4 8 fungizone). Prior to placement into microcentrifuge tubes, saliva was collected from mosquito 1 4 9 bodies on day 14 by positioning the proboscis of each mosquito into a capillary tube containing 1 5 0 8 approximately 10 µl of a 1:1 solution of 50% sucrose and FBS. After 30 minutes, the contents 1 5 1 were expelled in individual microcentrifuge tubes containing 0.3 ml of mosquito diluent, and 1 5 2 bodies were placed in individual microcentrifuge tubes containing 1 ml of mosquito diluent. A 5 1 5 3 mm stainless steel bead (Qiagen, Valencia, CA) was placed into microcentrifuge tubes 1 5 4 containing mosquito bodies and legs, homogenized in a mixer mill (Retsch, Haan, Germany) for 1 5 5 30 seconds at 24 cycles per second, and centrifuged for 1 minute at 8000 rpm. All mosquito 1 5 6 bodies, legs, and saliva were stored at -80°C until assayed. Samples were tested for RVFV infectious particles by plaque assay on Vero cells 1 5 8 according to previous published protocols [38] . Serial dilutions were prepared for all mosquito 1 5 9 body, leg, and saliva samples. One hundred microliters of each dilution was inoculated onto 1 6 0
Vero cell culture monolayers. Inoculated plates were incubated at 37°C for 1 hr and an agar 1 6 1 overlay was added (1X EBME, 0.75% agarose, 7% FBS, 1% penicillin streptomycin, and 1% 1 6 2 nystatin). Plates were incubated at 37°C for 4 days and then a second overlay (1X EBME, 0.75% 1 6 3 agarose, and 4% neutral red) was added. Plaques were counted 24 hr after application of the 1 6 4 second overlay and titers calculated. To evaluate relationships between Wolbachia density and RVFV titer, we measured homogenate using the DNeasy blood and tissue kit (Qiagen) and used as template for qPCR on a Rotor-Gene Q (Qiagen) with the PerfeCta SYBR FastMix kit (Quanta Biosciences, Beverly, 1 7 1 MA) or on ABI 7500 with Power SYBR green master mix (Applied Biosystems, Foster City, 1 7 2 CA). The qPCR assays were performed in 10µl reactions and amplification was carried out using 1 7 3 9 a standardized program at 95°C for 5 min, and 40 cycles of 95°C for 10 sec, 60°C for 15 sec, and 1 7 4 72°C for 10 sec. Wolbachia DNA was amplified with primers Alb-GF and Alb-GR [39] and was 1 7 5 normalized to the Cx. tarsalis actin gene by using qGene software [24, 40] . qPCRs were 1 7 6 performed in duplicate. Infection, dissemination, and transmission rates were compared between Wolbachia- for Windows (GraphPad Software, San Diego, CA). For all replicates, one blood fed mosquito from each treatment was tested for input 1 9 4 RVFV titers on the day of blood feeding. Time 0 results for Wolbachia-infected Cx. tarsalis 1 9 5 were as follows: replicate 1, 2.50 × 10 2 ; replicate 2, 7.00 × 10 6 ; replicate 3, 1.00 × 10 2 . 0 . Time 0 1 9 6 1 0 results for control Cx. tarsalis were as follows: replicate 1, 5.00 × 10 2 ; replicate 2, 1.05 × 10 7 ; 1 9 7 replicate 3, 1.00 ×10 2 . 0 . Viremias in the three hamsters were 10 4 , 10 9 , and 10 3 PFU/ml, To determine RVFV vector competence of Wolbachia-infected and Wolbachia-2 0 0 uninfected Cx. tarsalis, we examined frequencies of RVFV-positive bodies, legs, and saliva ( Fig.   2  0  1 1). Infection rate is the proportion of mosquito bodies that contained infectious RVFV. frequencies were significantly higher than replicate one for both treatments and at both day 7 and 2 0 8 day 14 (P < 0.0001). However, across replicates and time points, Wolbachia-infected Cx. tarsalis 2 0 9 infection, dissemination, and transmission rates did not differ significantly from Wolbachia-2 1 0 uninfected Cx. tarsalis (Fig. 1, Table S1 ). . Thus the data was pooled for further analysis. RVFV body and saliva titers were determined for Wolbachia-infected and control Cx. tarsalis. There were no significant differences in RVFV body titer or saliva titer between 2 1 3
Wolbachia-infected and control Cx. tarsalis at either day 7 or day 14 (Fig. 2) . Additionally, both 2 1 4
Wolbachia-infected and uninfected Cx. tarsalis that transmitted RVFV had significantly higher 2 1 5 RVFV body titers than non-transmitting mosquitoes ( Fig S1) . Wolbachia density in each mosquito was determined by qPCR. We analyzed 2 1 9 relationships between Wolbachia density and RVFV body titer and combined data from all 2 2 0 replicates. Overall, there was a moderate, negative correlation between Wolbachia density and 2 2 1 RVFV body titer at both day 7 and 14 (Fig. 3) . Wolbachia density was also compared across 2 2 2 time; Wolbachia concentration at day 14 was significantly higher than at day 7, consistent with 2 2 3
Wolbachia replication in mosquitoes ( Fig S3) . mosquitoes. These effects can include moderate to complete pathogen inhibition, as well as 2 2 8 pathogen enhancement [17, 22, 24, 41, 42] . In a previous study, we found that Wolbachia strain 2 2 9 wAlbB enhanced WNV infection frequency in Cx. tarsalis [24] , although in that study, viral 2 3 0 infection titers were not measured. To understand how widespread the Wolbachia-induced 2 3 1 enhancement phenotype is in Cx. tarsalis, we studied wAlbB effects on RVFV, an important 2 3 2 arthropod-borne virus with potential to invade the United States [43, 44] . In contrast to our 2 3 3 previous results, we found that wAlbB did not affect RVFV body or saliva titers, nor RVFV 2 3 4 infection, dissemination, or transmission frequencies in Cx. tarsalis. studies have reported that high densities of Wolbachia are more likely than low densities to block 2 3 7 viruses in Drosophila spp. and mosquitoes [45] [46] [47] [48] . Similarly, we found a moderate, negative 2 3 8 correlation between RVFV body titer and Wolbachia density. High Wolbachia levels were 2 3 9 associated with RVFV negative mosquitoes and very low RVFV body titers. The low numbers of 2 4 0 mosquitoes at the high Wolbachia densities may explain why we did not see a Wolbachia effect 2 4 1 1 2 on population level vector competence measures. However, our correlation data suggests that in 2 4 2 this system, Wolbachia may suppress RVFV in a density-dependent manner.
4 3
In this Cx. tarsalis-wAlbB system, we have reported different effects of Wolbachia on 2 4 4 vector competence for WNV and RVFV [24] . Other studies have found similar differences in 2 4 5
Wolbachia phenotypes and suggested they may depend on various factors including 2 4 6 environmental conditions, and pathogen type [20, 49] . RVFV and WNV belong to different virus 2 4 7 families and could interact with the mosquito host environment and Wolbachia in different ways. 
